From then to now: the role of antibodies in our response to COVID-19
In January 2020, the Director-General of the World Health Organization declared the outbreak of COVID-19 to be a Public Health Emergency of International Concern. For scientists, this confirmed the...
How COVID-19 has changed the biomedical industry
The shift in research priorities due to COVID-19 has required rapid adjustment across the biomedical sector. The speed and effectiveness of this response supports our current scientific understanding...
How COVID-19 has affected the non-human primate shortage
Why is the shortage in non-human primates such a serious issue for the scientific community? Non-human primates (NHPs) are critical for clinical development pathways of new drug applications, but NHP...